Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan-Reference-Cited by-同舟云学术

Real-World Study of Lanreotide Autogel in Routine Practice in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Hong Kong and Taiwan

Published:2024-08-31 Issue: Volume: Page:
ISSN:2366-1070
Container-title:Oncology and Therapy
language:en
Short-container-title:Oncol Ther

Author:

Chen Jen-Shi^ORCID,Bai Li-Yuan^ORCID,Cheng Hsiao-Hsiang,Chan Stephen Lam^ORCID,Zou Ji-Yan,Shi Xiaofeng,Houchard Aude,Truong-Thanh Xuan-Mai,Chen Ming-Huang

Funder

Ipsen

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40487-024-00302-6.pdf

Reference39 articles.

1. Oronsky B, Ma PC, Morgensztern D, Carter CA. Nothing but NET: a review of neuroendocrine tumors and carcinomas. Neoplasia. 2017;19(12):991–1002. https://doi.org/10.1016/j.neo.2017.09.002.

2. Das S, Dasari A. Epidemiology, incidence, and prevalence of neuroendocrine neoplasms: are there global differences? Curr Oncol Rep. 2021;23(4):43. https://doi.org/10.1007/s11912-021-01029-7.

3. Uri I, Grozinsky-Glasberg S. Current treatment strategies for patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Clin Diabetes Endocrinol. 2018;4(1):16. https://doi.org/10.1186/s40842-018-0066-3.

4. Klimstra DS, Kloppell G, La Rosa S, Rindi G. Classification of neuroendocrine neoplasms of the digestive system. In: WHO Classification of Tumours Editorial Board (ed). WHO Classification of Tumours: Digestive System Tumours, 5th edn. Lyon: International Agency for Research on Cancer, 2019; 16.

5. Kim JY, Hong S-M, Ro JY. Recent updates on grading and classification of neuroendocrine tumors. Ann Diagn Pathol. 2017;29:11–6. https://doi.org/10.1016/j.anndiagpath.2017.04.005.